A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints

Author： Sugimoto Tomoyuki   Sozu Takashi   Hamasaki Toshimitsu   Evans Scott R.  

Publisher： Oxford University Press

ISSN： 1465-4644

Source： Biostatistics, Vol.14, Iss.3, 2013-07, pp. : 409-421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Which Endpoints to Use in Clinical Trials in Venous Thromboembolism?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 108-108

Karger

Access to resources Recommend Favorite

Recognizing the problem of delayed entry in time‐to‐event studies: Better late than never for clinical neuroscientists

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 6, 2015-12 ,pp. : 839-844

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain

By Silberstein S. D.  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 861-867

Informa Healthcare

Access to resources Recommend Favorite

Trials are meaningful for clinical decision making only when their endpoints are valid and comparable

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 5, 2015-05 ,pp. : 1175-1177

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Bayesian model for time-to-event data with informative censoring

By Kaciroti Niko A.   Raghunathan Trivellore E.   Taylor Jeremy M. G.   Julius Stevo  

Biostatistics, Vol. 13, Iss. 2, 2012-04 ,pp. : 341-354

Oxford University Press

Access to resources Recommend Favorite